DFX Intelligence

Scott David Morenstein

Role unknown· NY

As of 2026-09-12 · this person's identity; each section below carries its own date

Current roles: 0
Investments attributed: 2
Board seats: 1

Ask DFX about this View relationships Find contacts Investments Board seats

As of 2026-09-12 · this person's identity; each section below carries its own date

Nothing material in the last 365 days. Last change: 18 Jul 2018, Latest Velicept Therapeutics Form D equity offering ($15.5M) on 18 Jul 2018.

Relationship network

2 connected entities2 observed investment recordsinvestment records 2015 to 2018

From the roles sources name this person in, the investments a source attributes to them, and the boards and funds Form D names them on.

Scott David Morenstein

Reading the network

Organization
Company

Venture relationships are not scored. Each line names its claim: a round led or joined, a board seat or a filing that names the firm, a listing on a portfolio page (dated by when DFX saw it, never by when the investment was made), a disclosed LP commitment, or a co-investor pair counted from observed participations. Observed means a named source says so; Derived means DFX counted it from observed rows; Inferred means a match that may be wrong.

Darker lines were active in the last 24 months or are current; lighter lines are older or undated.

Ask DFX about this network

Which companies and boards is Scott David Morenstein connected to?

How am I connected?

Name your firm, a company or a person, and DFX finds the published routes to Scott David Morenstein: a shared portfolio company or board, a prior employer, a co-investor, a shared LP or service provider. Every step is a filed or published record with its source; none is a guess about who knows whom.

See how you connect to Scott David Morenstein

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Drawing the relationship network…

Roles

0 current, 1 past

Valence Life Sciences, LLC Managing Director
Jan 1, 2012 to Mar 24, 2014 · “Listed on Schedule A of filing 2013-06-07 as MANAGING DIRECTOR, absent from filing 2014-03-24”
Inference Form ADV

Investments attributed to this person

Company	Round	Investor	Attribution	Date	Source
Velicept Therapeutics, Inc.	Form D equity offering · $15.5M	Valence Life Sciences, LLC	strongly supported · board	Jul 18, 2018	Inference sec.gov
Velicept Therapeutics, Inc.	Form D equity offering · $12.0M	Valence Life Sciences, LLC	strongly supported · board	Dec 1, 2015	Inference sec.gov

Board seats and vehicles

1 board, 0 vehicles

Velicept Therapeutics, Inc. board seat on a deal Jul 18, 2018 Inference

Timeline

6 dated entries: events, attributed deals, board seats and role changes

Jul 18, 2018
Form D equity offering in Velicept Therapeutics, Inc. (Valence Life Sciences, LLC)
Attributed investment Inference Velicept Therapeutics, Inc. Form D
Dec 1, 2015
Form D equity offering in Velicept Therapeutics, Inc. (Valence Life Sciences, LLC)
Attributed investment Inference Velicept Therapeutics, Inc. Form D
Mar 24, 2014
Scott David Morenstein (Managing Director) no longer on Schedule A of Valence Life Sciences, LLC
Person left Inference Valence Life Sciences, LLC Form ADV
Mar 24, 2014
Left Valence Life Sciences, LLC as Managing Director
Role ended Inference Valence Life Sciences, LLC Form ADV
Jan 1, 2012
Scott David Morenstein joined Schedule A of Valence Life Sciences, LLC as Managing Director
Person joined Fact Valence Life Sciences, LLC Form ADV

Full timeline · 6 entriesnewest first

Jul 18, 2018
Form D equity offering in Velicept Therapeutics, Inc. (Valence Life Sciences, LLC)
Attributed investment Inference Velicept Therapeutics, Inc. Form D
Dec 1, 2015
Form D equity offering in Velicept Therapeutics, Inc. (Valence Life Sciences, LLC)
Attributed investment Inference Velicept Therapeutics, Inc. Form D
Mar 24, 2014
Scott David Morenstein (Managing Director) no longer on Schedule A of Valence Life Sciences, LLC
Person left Inference Valence Life Sciences, LLC Form ADV
Mar 24, 2014
Left Valence Life Sciences, LLC as Managing Director
Role ended Inference Valence Life Sciences, LLC Form ADV
Jan 1, 2012
Scott David Morenstein joined Schedule A of Valence Life Sciences, LLC as Managing Director
Person joined Fact Valence Life Sciences, LLC Form ADV
Jan 1, 2012
Joined Valence Life Sciences, LLC as Managing Director
Role began Inference Valence Life Sciences, LLC Form ADV

Record history

2 dated events on the change ledger, latest event first

Person left
2014-03-24source on record
Person joined
2012-01-01source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.